GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (NAS:AUTL) » Definitions » Future Policy Benefits

AUTL (Autolus Therapeutics) Future Policy Benefits


View and export this data going back to 2018. Start your Free Trial

What is Autolus Therapeutics Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


Autolus Therapeutics Business Description

Traded in Other Exchanges
Address
191 Wood Lane, The MediaWorks, London, GBR, W12 7FP
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.